As we transition into 2025, several key issues from 2024 will continue to impact the pharmacy benefit landscape, along with a few new developments…
At National CooperativeRx, we take pride in fostering professional growth and celebrating the achievements of our team members. As the year comes to a close, we are thrilled to recognize several internal promotions…
Expect another year of non-specialty drugs surpassing specialty drugs in their overall contributions to trend. GLP-1s will continue to be major drivers.
As a sales and account associate, Zach supports our strategic account executives and clinical team in fostering relationships with existing members and partners.
Offering rebates has been a pricing strategy for manufacturers of brand-named prescription drugs for decades. The explosion of rebate value has happened over the last 10-12 years as pharmacy benefit managers (PBMs)
In this final part of the series, we will dive into PBM performance and support—answering questions about how PBMs gauge plan effectiveness and provide support to stakeholders.
